Atlas Trials

A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

Clinical trial NCT05105672 · UNKNOWN

Trial details

NCT number
NCT05105672
Sponsor
The Affiliated Hospital of Xuzhou Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Uterine Cervical NeoplasmsSintilimab
Start date
2021-03-08
Primary completion
2023-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.